4894.T JPX
Cuorips Inc.
1W: +5.6%
1M: +7.9%
3M: +44.7%
YTD: -27.3%
1Y: -4.1%
3Y: +175.7%
¥6,610.00 ($41.89)
+350.00 (+5.59%)
Weekly Expected Move ±11.9%
¥4769
¥5515
¥6260
¥7005
¥7751
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Smart Money Score
No convergence signal
Key Statistics
Market Cap¥51.7B ($327.6M)
52W Range3610-12400
Volume287,800
Avg Volume127,960
Beta0.88
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOTakayuki Kusanagi
Employees51
SectorHealthcare
IndustryBiotechnology
IPO Date2023-06-27
Websitecuorips.co.jp
Nakanoshima Qross 8F, O-Nexus
Osaka 530-0005
JP
Osaka 530-0005
JP
81 3 6231 0043
About Cuorips Inc.
Cuorips Inc. specializes in the comprehensive lifecycle of iPS cell-derived cardiomyocyte sheets, undertaking their research, development, production, commercialization, and distribution. The firm's portfolio extends to include cellular, tissue-based, and cell processing products. Furthermore, it offers contract development and manufacturing services, alongside expert consulting. The company, which was incorporated in 2017 and is based in Tokyo, Japan, previously operated under the name Cuore Inc. before adopting Cuorips Inc. in June 2017.
Latest News
No recent news
Recent Insider Trades
No insider trades found